Drugs / DT-Polio®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00447525 Comparator | Feb 2007 → Jan 2008 | diphtheria, poliomyelitis, tetanus | Sanofi Pasteur, a Sanofi Company | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DT-Polio | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00447525 ↗ |
| Modality | Vaccine | “Comparison of the Immunogenicity and Safety of a Combined Adsorbed Low Dose Diphtheria, Tetanus and Inactivated Poliomyelitis Vaccine (REVAXIS®) With a Combined Diphtheria,...” NCT00447525 ↗ |
| Route | Intramuscular | “Children were randomly assigned to receive a single intramuscular dose of REVAXIS or DT Polio.” PMID 21441781 ↗ May 2011 |